AAAAAA

   
Results: 1-25 | 26-44 |
Results: 26-44/44
Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics
Authors: Vasen, HFA Haites, NE Evans, DGR Steel, CM Moller, P Hodgson, S Eccles, D Morrison, P Stoppa-Lyonnet, D Chang-Claude, J Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics, DIS MARKER, 15(1-3), 1999, pp. 47-47
Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes
Authors: Chang-Claude, J Becher, H Caligo, M Eccles, D Evans, G Haites, N Hodgson, S Moller, P Weber, BHF Stoppa-Lyonnet, D
Citation: J. Chang-claude et al., Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes, DIS MARKER, 15(1-3), 1999, pp. 53-65
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
Authors: Stoppa-Lyonnet, D Caligo, M Eccles, D Evans, DGR Haites, NE Hodgson, NS Moller, P Morrison, PJ Steel, CM Vasen, HFA Chang-Claude, J
Citation: D. Stoppa-lyonnet et al., Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?, DIS MARKER, 15(1-3), 1999, pp. 67-68
Ethical, social and economic issues in familial breast cancer: a compilation of views from the EC biomed II demonstration project
Authors: Steel, M Smyth, E Vasen, H Eccles, D Evans, G Moller, P Hodgson, S Stoppa-Lyonnet, D Chang-Claude, J Caligo, M Morrison, P Haites, N
Citation: M. Steel et al., Ethical, social and economic issues in familial breast cancer: a compilation of views from the EC biomed II demonstration project, DIS MARKER, 15(1-3), 1999, pp. 125-131
Utilisation of prophylactic mastectomy in 10 European centers
Authors: Evans, DGR Anderson, E Lalloo, F Vasen, H Beckmann, M Eccles, D Hodgson, S Moller, P Chang-Claude, J Morrison, P Stoppa-Lyonnet, D Steel, M Haites, N
Citation: Dgr. Evans et al., Utilisation of prophylactic mastectomy in 10 European centers, DIS MARKER, 15(1-3), 1999, pp. 148-151
Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe
Authors: Morrison, PJ Steel, CM Vasen, HFA Eccles, D Evans, DGR Moller, P Hodgson, S Stoppa-Lyonnet, D Chang-Claude, J Caligo, M Olah, E Haites, NE Nevin, NC
Citation: Pj. Morrison et al., Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe, DIS MARKER, 15(1-3), 1999, pp. 159-165
Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
Authors: Moller, P Evans, G Haites, N Vasen, H Reis, MM Anderson, E Apold, J Hodgson, S Eccles, D Olsson, H Stoppa-Lyonnet, D Chang-Claude, J Morrison, PJ Bevilacqua, G Heimdal, K Maehle, L Lalloo, F Gregory, H Preece, P Borg, A Nevin, NC Caligo, M Steel, CM
Citation: P. Moller et al., Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer, DIS MARKER, 15(1-3), 1999, pp. 207-211
Genetic testing for breast cancer predisposition
Authors: Gauthier-Villars, M Gad, S Caux, V Pages, S Blandy, C Stoppa-Lyonnet, D
Citation: M. Gauthier-villars et al., Genetic testing for breast cancer predisposition, SURG CL NA, 79(5), 1999, pp. 1171
Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer
Authors: Shugart, YY Cour, C Renard, H Lenoir, G Goldgar, D Teare, D Easton, D Rahman, N Gusterton, R Seal, S Barfoot, R Stratton, M Mangion, J Peelen, T van den Ouweland, A Meijers, H Devilee, P Eccles, D Lynch, H Weber, B Stoppa-Lyonnet, D Bignon, YJ
Citation: Yy. Shugart et al., Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer, J MED GENET, 36(9), 1999, pp. 720-721
No evidence for germline PTEN mutations in families with breast and brain tumours
Authors: Lauge, A Lefebvre, C Laurent-Puig, P Caux, V Gad, S Eng, C Longy, M Stoppa-Lyonnet, D
Citation: A. Lauge et al., No evidence for germline PTEN mutations in families with breast and brain tumours, INT J CANC, 84(3), 1999, pp. 216-219
Germline brca2 sequence variants in patients with ocular melanoma
Authors: Sinilnikova, OM Egan, KM Quinn, JL Boutrand, L Lenoir, GM Stoppa-Lyonnet, D Desjardins, L Levy, C Goldgar, D Gragcoudas, ES
Citation: Om. Sinilnikova et al., Germline brca2 sequence variants in patients with ocular melanoma, INT J CANC, 82(3), 1999, pp. 325-328
Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions
Authors: Puget, N Stoppa-Lyonnet, D Sinilnikova, OM Pages, S Lynch, HT Lenoir, GM Mazoyer, S
Citation: N. Puget et al., Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions, CANCER RES, 59(2), 1999, pp. 455-461
Recommendations for medical management of hereditary breast and ovarian cancer: the Inserm-FNCLCC ad hoc committee
Authors: Eisinger, F Alby, N Bremond, A Dauplat, J Espie, M Janiaud, P Kuttenn, F Lebrun, JP Lefranc, JP Pierret, J Sobol, H Stoppa-Lyonnet, D Thouvenin, D Tristant, H Feingold, J
Citation: F. Eisinger et al., Recommendations for medical management of hereditary breast and ovarian cancer: the Inserm-FNCLCC ad hoc committee, B CANCER, 86(3), 1999, pp. 307-313
Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families
Authors: Janin, N Andrieu, N Ossian, K Lauge, A Croquette, MF Griscelli, C Debre, M Bressac-de-Paillerets, B Aurias, A Stoppa-Lyonnet, D
Citation: N. Janin et al., Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families, BR J CANC, 80(7), 1999, pp. 1042-1045
Recommendations for medical management of hereditary breast and ovarian cancer: the INSERM-FNCLCC ad hoc committee
Authors: Eisinger, F Alby, N Bremond, A Dauplat, J Espie, M Janiaud, P Kuttenn, F Lebrun, JP Lefranc, JP Pierret, J Sobol, H Stoppa-Lyonnet, D Thouvenin, D Tristant, H Feingold, J
Citation: F. Eisinger et al., Recommendations for medical management of hereditary breast and ovarian cancer: the INSERM-FNCLCC ad hoc committee, ANN GENET, 42(1), 1999, pp. 51-64
Evidence for a BRCA1 founder mutation in families of west African ancestry
Authors: Mefford, HC Baumbach, L Panguluri, RCK Whitfield-Broome, C Szabo, C Smith, S King, MC Dunston, G Stoppa-Lyonnet, D Arena, F
Citation: Hc. Mefford et al., Evidence for a BRCA1 founder mutation in families of west African ancestry, AM J HU GEN, 65(2), 1999, pp. 575-578
An Alu-mediated 6-kb duplication in the BRCA1 gene: A new founder mutation?
Authors: Puget, N Sinilnikova, OM Stoppa-Lyonnet, D Audoynaud, C Pages, S Lynch, HT Goldgar, D Lenoir, GM Mazoyer, S
Citation: N. Puget et al., An Alu-mediated 6-kb duplication in the BRCA1 gene: A new founder mutation?, AM J HU GEN, 64(1), 1999, pp. 300-302
Recommendations for medical management of hereditary breast and ovarian cancer: The INSERM-FNCLCC ad hoc committee
Authors: Eisinger, F Alby, N Bremond, A Dauplat, J Espie, M Janiaud, P Kuttenn, F Lebrun, JP Lefranc, JP Pierret, J Sobol, H Stoppa-Lyonnet, D Thouvenin, D Tristant, H Feingold, J
Citation: F. Eisinger et al., Recommendations for medical management of hereditary breast and ovarian cancer: The INSERM-FNCLCC ad hoc committee, ANN ENDOCR, 59(6), 1998, pp. 470-484
Implication of germline BRCA2 gene mutations for the occurrence of ocular melanoma and pancreatic cancer
Authors: Serova-Sinilnikova, O Egan, K Boutrand, L Stoppa-Lyonnet, D Desjardins, L Levy, C Bignon, YJ Lasset, C Haguenauer, O Goldgar, D Lenoir, GM
Citation: O. Serova-sinilnikova et al., Implication of germline BRCA2 gene mutations for the occurrence of ocular melanoma and pancreatic cancer, EUROCANCER 98, 1998, pp. 113-114
Risultati: 1-25 | 26-44 |